Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/2267
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorPRINA, Elena-
dc.contributor.authorFERRER, Miquel-
dc.contributor.authorRANZANI, Otavio T.-
dc.contributor.authorPOLVERINO, Eva-
dc.contributor.authorCILLONIZ, Catia-
dc.contributor.authorMORENO, Encarnacion-
dc.contributor.authorMENSA, Josep-
dc.contributor.authorMONTULL, Beatriz-
dc.contributor.authorMENENDEZ, Rosario-
dc.contributor.authorCOSENTINI, Roberto-
dc.contributor.authorTORRES, Antoni-
dc.date.accessioned2013-09-23T16:50:35Z-
dc.date.available2013-09-23T16:50:35Z-
dc.date.issued2013-
dc.identifier.citationCHEST, v.143, n.3, p.767-775, 2013-
dc.identifier.issn0012-3692-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/2267-
dc.description.abstractBackground: Thrombocytosis, often considered a marker of normal inflammatory reaction of infections, has been recently associated with increased mortality in hospitalized patients with community-acquired pneumonia (CAP). We assessed the characteristics and outcomes of patients with CAP and thrombocytosis (platelet count >= 4 x 10(5)/mm(3)) compared with thrombocytopenia (platelet count <10(5)/mm(3)) and normal platelet count. Methods: We prospectively analyzed 2,423 consecutive, hospitalized patients with CAP. We excluded patients with immunosuppression, neoplasm, active TB, or hematologic disease. Results: Fifty-three patients (2%) presented with thrombocytopenia, 204 (8%) with thrombocytosis, and 2,166 (90%) had normal platelet counts. Patients with thrombocytosis were younger (P < .001); those with thrombocytopenia more frequently had chronic heart and liver disease (P < .001. for both). Patients with thrombocytosis presented more frequently with respiratory complications, such as complicated pleural effusion and empyema (P < .001), whereas those with thrombocytopenia presented more often with severe sepsis (P < .001), septic shock (P = .009), need for invasive mechanical ventilation (P < .001), and ICU admission (P = .011). Patients with thrombocytosis and patients with thrombocytopenia had longer hospital stays (P = .004), and higher 30-day mortality (P = .001) and readmission rates (P = .011) than those with normal platelet counts. Multivariate analysis confirmed a significant association between thrombocytosis and 30-day mortality (OR, 2.720; 95% CI, 1.589-4.657; P < .001). Adding thrombocytosis to the confusion, respiratory rate, and BP plus age >= 65 years score slightly improved the accuracy to predict mortality (area under the receiver operating characteristic curve increased from 0.634 to 0.654, P = .049). Conclusions: Thrombocytosis in patients with CAP is associated with poor outcome, complicated pleural effusion, and empyema. The presence of thrombocytosis in CAP should encourage ruling out respiratory complication and could be considered for severity evaluation. CHEST 2013; 143(3):767-775-
dc.description.sponsorshipCentro de Investigacion Biomedica en Red-Enfermedades Respiratorias-Instituto de Salud Carlos III [CibeRes CB06/06/0028, 2009 SGR 911]-
dc.description.sponsorshipPII de infecciones respiratorias of SEPAR-
dc.description.sponsorshipIDIBAPS-
dc.language.isoeng-
dc.publisherAMER COLL CHEST PHYSICIANS-
dc.relation.ispartofChest-
dc.rightsrestrictedAccess-
dc.rightsrestrictedAccess-
dc.subject.otherintensive-care-unit-
dc.subject.otherparapneumonic effusion-
dc.subject.otherantimicrobial therapy-
dc.subject.otherplatelet count-
dc.subject.othersevere sepsis-
dc.subject.otherseptic shock-
dc.subject.otherrisk-factors-
dc.subject.otherguidelines-
dc.subject.othermanagement-
dc.subject.otherseverity-
dc.titleThrombocytosis Is a Marker of Poor Outcome in Community-Acquired Pneumonia-
dc.typearticle-
dc.rights.holderCopyright AMER COLL CHEST PHYSICIANS-
dc.identifier.doi10.1378/chest.12-1235-
dc.identifier.pmid23187959-
dc.subject.wosCritical Care Medicine-
dc.subject.wosRespiratory System-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalPRINA, Elena:Univ Barcelona, IDIBAPS, Hosp Clin, Serv Pneumol,Inst Torax, E-08007 Barcelona, Spain; Osped Maggiore Policlin, Dept Emergency Med, Carattere Sci Fdn Ca Granda, Milan, Italy-
hcfmusp.author.externalFERRER, Miquel:Univ Barcelona, IDIBAPS, Hosp Clin, Serv Pneumol,Inst Torax, E-08007 Barcelona, Spain; Ctr Invest Biomed Red Enfermedades Resp, Barcelona, Spain-
hcfmusp.author.externalPOLVERINO, Eva:Univ Barcelona, IDIBAPS, Hosp Clin, Serv Pneumol,Inst Torax, E-08007 Barcelona, Spain; Ctr Invest Biomed Red Enfermedades Resp, Barcelona, Spain-
hcfmusp.author.externalCILLONIZ, Catia:Univ Barcelona, IDIBAPS, Hosp Clin, Serv Pneumol,Inst Torax, E-08007 Barcelona, Spain; Ctr Invest Biomed Red Enfermedades Resp, Barcelona, Spain-
hcfmusp.author.externalMORENO, Encarnacion:Univ Barcelona, IDIBAPS, Hosp Clin, Serv Pneumol,Inst Torax, E-08007 Barcelona, Spain; Ctr Invest Biomed Red Enfermedades Resp, Barcelona, Spain-
hcfmusp.author.externalMENSA, Josep:Hosp Clin Barcelona, IDIBAPS, Serv Enfermedades Infecciosas, E-08036 Barcelona, Spain-
hcfmusp.author.externalMONTULL, Beatriz:Hosp Univ La Fe, Serv Neumol, Valencia, Spain-
hcfmusp.author.externalMENENDEZ, Rosario:Ctr Invest Biomed Red Enfermedades Resp, Barcelona, Spain; Hosp Univ La Fe, Serv Neumol, Valencia, Spain-
hcfmusp.author.externalCOSENTINI, Roberto:Osped Maggiore Policlin, Dept Emergency Med, Carattere Sci Fdn Ca Granda, Milan, Italy-
hcfmusp.author.externalTORRES, Antoni:Univ Barcelona, IDIBAPS, Hosp Clin, Serv Pneumol,Inst Torax, E-08007 Barcelona, Spain; Ctr Invest Biomed Red Enfermedades Resp, Barcelona, Spain-
hcfmusp.description.beginpage767-
hcfmusp.description.endpage775-
hcfmusp.description.issue3-
hcfmusp.description.volume143-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84874989368-
hcfmusp.origem.idWOS:000317871300031-
hcfmusp.publisher.cityNORTHBROOK-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceASHBAUGH DG, 1991, CHEST, V99, P1162, DOI 10.1378/chest.99.5.1162-
hcfmusp.relation.referenceBodi M, 2005, CLIN INFECT DIS, V41, P1709, DOI 10.1086/498119-
hcfmusp.relation.referenceBrogly N, 2007, J INFECTION, V55, P136, DOI 10.1016/j.jinf.2007.01.011-
hcfmusp.relation.referenceBRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968-
hcfmusp.relation.referenceChalmers JD, 2009, THORAX, V64, P592, DOI 10.1136/thx.2008.105080-
hcfmusp.relation.referenceCilloniz C, 2012, CLIN MICROBIOL INFEC, V18, P1134, DOI 10.1111/j.1469-0691.2011.03692.x-
hcfmusp.relation.referenceCilloniz C, 2011, THORAX, V66, P340, DOI 10.1136/thx.2010.143982-
hcfmusp.relation.referenceCunha BA, 2011, CHEST, V139, P1255, DOI 10.1378/chest.10-3146-
hcfmusp.relation.referenceDellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41-
hcfmusp.relation.referenceDodig S, 2005, ARCH MED RES, V36, P124, DOI 10.1016/j.arcmed.2004.12.011-
hcfmusp.relation.referenceFalguera M, 2011, EUR RESPIR J, V38, P1173, DOI 10.1183/09031936.00000211-
hcfmusp.relation.referenceFELDMAN C, 1989, INTENS CARE MED, V15, P302-
hcfmusp.relation.referenceFine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402-
hcfmusp.relation.referenceFolsom AR, 1999, CIRCULATION, V100, P736-
hcfmusp.relation.referenceGeorges H, 2010, CHEST, V138, P1279, DOI 10.1378/chest.10-0871-
hcfmusp.relation.referenceGrijalva CG, 2011, THORAX, V66, P663, DOI 10.1136/thx.2010.156406-
hcfmusp.relation.referenceHANLEY JA, 1983, RADIOLOGY, V148, P839-
hcfmusp.relation.referenceKatz JN, 2011, CHEST, V139, P658, DOI 10.1378/chest.10-1971-
hcfmusp.relation.referenceLIGHT RW, 1980, AM J MED, V69, P507, DOI 10.1016/0002-9343(80)90460-X-
hcfmusp.relation.referenceLim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377-
hcfmusp.relation.referenceMandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159-
hcfmusp.relation.referenceMeade TW, 1997, THROMB HAEMOSTASIS, V78, P926-
hcfmusp.relation.referenceMenendez R, 2007, CHEST, V132, P1348, DOI 10.1378/chest.06-1995-
hcfmusp.relation.referenceMirsaeidi M, 2010, CHEST, V137, P416, DOI 10.1378/chest.09-0998-
hcfmusp.relation.referenceNiederman MS, 2001, AM J RESP CRIT CARE, V163, P1730-
hcfmusp.relation.referenceNIEDERMAN MS, 1993, AM REV RESPIR DIS, V148, P1418-
hcfmusp.relation.referenceRamirez P, 2011, CRIT CARE MED, V39, P2211, DOI 10.1097/CCM.0b013e3182257445-
hcfmusp.relation.referenceSmyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x-
hcfmusp.relation.referenceStrauss R, 2002, CRIT CARE MED, V30, P1765, DOI 10.1097/00003246-200208000-00015-
hcfmusp.relation.referencevan der Bom JG, 2009, J THROMB HAEMOST, V7, P399, DOI 10.1111/j.1538-7836.2008.03267.x-
hcfmusp.relation.referenceVandijck DM, 2010, HEART LUNG, V39, P21, DOI 10.1016/j.hrtlng.2009.07.005-
hcfmusp.relation.referenceWOLACH B, 1990, PEDIATR INFECT DIS J, V9, P718, DOI 10.1097/00006454-199010000-00007-
hcfmusp.relation.referenceYeaman MR, 1997, CLIN INFECT DIS, V25, P951, DOI 10.1086/516120-
hcfmusp.relation.referenceZakai NA, 2007, J THROMB HAEMOST, V5, P1128, DOI 10.1111/j.1538-7836.2007.02528.x-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipInstituto de Salud Carlos III-
hcfmusp.citation.scopus36-
hcfmusp.scopus.lastupdate2022-05-06-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/09
LIM/09 - Laboratório de Pneumologia

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_RANZANI_Thrombocytosis_Is_a_Marker_of_Poor_Outcome_in_2013.PDF
  Restricted Access
publishedVersion (English)664.39 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.